AzTrials
AzTrials

Water BirthAQUAMODANCT06441370

Patient Satisfaction During Physiological Water or Land Birth: a Prospective Study in an French Tertiary Maternity Unit.

An observational study of Water Birth, run by Tourcoing Hospital at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A study will be carried out to compare the level of satisfaction and psychological state of women who give birth in water with those who give birth out of water. The aim is to demonstrate the benefits of water birth and justify its place in the healthcare offering. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Water Birth
What is being tested?
waterbirth
Type of treatment
Surgery or procedure
How many people
1,200 participants
Where
1 siteFrance
Study dates
1 Apr 2024to 1 Jun 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: All patients who have chosen to give birth physiologically at the Maternity unit will be offered the study during their maternity stay.

Who may be able to join

  • Major patient
  • Social security beneficiary
  • Presence of a companion
  • Delivery greater than or equal to 37 weeks of amenorhoea
  • Spontaneous labor
  • Cephalic presentation
  • Physiological delivery by woman's choice according to 2017 HAS criteria (French recommendations)

Who cannot join

  • Patient under court protection
  • Patient under guardianship or curatorship
  • Placement of an epidural
  • Language barrier
  • Unexpected delivery (unwanted by the woman)
  • Scarred uterus
Show all 12Show fewer
  • Meconium fluid
  • Maternal pathologies: epilepsy, MS (depending on neurological opinion), diabetes (types 1 and 2), herpes infection, HIV, HBV, HCV
  • History of delivery hemorrhage > 1L
  • History of shoulder dystocia/clavicle fracture
  • Metrorrhagia
  • Administration of nalbuphine within 2 hours of birth.

Trial locations and contacts

1 site in 1 country.

Vitagliano JV Jean-Jacques, PhD contact

03.20.69.42.80

jjvitagliano@ch-tourcoing.fr

Degrendel MD Maxime, MD contact

03.20.69.42.80

mdegrendel@ch-tourcoing.fr

France1 site, 1 recruiting
  • Tourcoing Hospital

    Tourcoing, Hauts-de-France, 59200

    Vitagliano JV Jean_Jacques, PhD, 03.20.69.42.80, jvitagliano@ch-tourcoing.fr

    Degrendel MD Maxime, MD, 03.20.69.42.80, mdegrendel@ch-tourcoing.fr

    Recruiting

Other trials in France

About this study

Official title: Patient Satisfaction With Physiological Childbirth in Water or on Land a Prospective Study at the Tourcoing Hospital Maternity Unit

A study will be carried out to compare the level of satisfaction and psychological state of women who give birth in water with those who give birth out of water.

The aim is to demonstrate the benefits of water birth and justify its place in the healthcare offering.

Conditions
Water Birth
Being tested
waterbirth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • waterbirthProcedure or surgery

    waterbirth: laboured for all or part of the first stage of labour and remained in the water for birth of newborn

Study groups in NCT06441370
Study groupRoleWhat they receive
women with water birthsNot described
Receives: Procedure: waterbirth
women giving birth on landNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perceived control over childbirth

    The "perception of control over childbirth" dimension of the QEVA (Quality and Experience of Childbirth), a long version with a total of 6 dimensions. The score associated with the "perception of control over childbirth" dimension is obtained by averaging responses to items 8, 10, 11, 12, 14 and 18 of the questionnaire. The response to each of these items is coded on a Likert scale from 1 to 4, with a high value corresponding to poor control.

    Measured: This questionnaire will be achieved by participating women within 3 days postpartum, before discharge from the maternity ward.

Secondary outcomes (3)
  1. Dimension of the quality and experience of childbirth within 3 days of delivery

    The scores associated with the 5 other dimensions of the QEVA questionnaire:

    • Expectations, defined by items 9, 15 and 20;
    • Sensory experience, defined by items 3 and 16;
    • Relationship with caregivers, defined by items 5, 6, 7 and 13;
    • Emotions, defined by items 1, 2, 4, 21, 22, 23 and 24;
    • First moments with baby, defined by items 17, 18 and 19; Answers to the questions are coded on Likert scales from 1 to 4. Each score is calculated by averaging the responses to the questions in the dimension in question.

    Measured: This questionnaire is to be completed within 3 days of delivery, before discharge from the maternity hospital.

  2. Dimension of the quality and experience of childbirth within 2 months of delivery

    The scores associated with the 5 other dimensions of the QEVA questionnaire:

    • Expectations, defined by items 9, 15 and 20;
    • Sensory experience, defined by items 3 and 16;
    • Relationship with caregivers, defined by items 5, 6, 7 and 13;
    • Emotions, defined by items 1, 2, 4, 21, 22, 23 and 24;
    • First moments with baby, defined by items 17, 18 and 19; Answers to the questions are coded on Likert scales from 1 to 4. Each score is calculated by averaging the responses to the questions in the dimension in question.

    Measured: This questionnaire is to be completed within 2 months of delivery.

  3. Anxiety and depression at 2 months of delivery.

    The Edinburgh Postnatal Depression Scale (EPDS) will be used to assess anxiety and depression and depression at 2 months postpartum in order to screen for possible postpartum depression.

    Measured: This questionnaire is to be completed within 2 months of delivery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jun 2024
  2. Study start1 Apr 2024
  3. Primary completion1 Apr 2026 (estimated)
  4. Study completion1 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06441370
Sponsor's protocol ID
22.01415.000084
Acronym
AQUAMODA
Status last verified
May 2024
First submitted
28 May 2024
Last updated
4 Jun 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Water Birth, run by Tourcoing Hospital at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Vitagliano JV Jean-Jacques, PhD (03.20.69.42.80, jjvitagliano@ch-tourcoing.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Perceived control over childbirth (time frame: This questionnaire will be achieved by participating women within 3 days postpartum, before discharge from the maternity ward.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in